Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

1.2K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.2K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

627
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
627
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

4.8K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.8K
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

788
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
788
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

1.0K
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.0K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

767
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
767

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expert Clinical Consensus on Body Surface Gastric Mapping Phenotypes for Gastroduodenal Disorders: 'Auckland Classification' v1.0.

Neurogastroenterology and motility·2026
Same author

A Clinical Practice Update for the Management of Patients With Disorders of Gut-Brain Interaction and Altered Food Intake Behavior.

Neurogastroenterology and motility·2026
Same author

Symptom Patterns Outside the Rome IV Consensus in Eastern and Western Patients With a Disorder of Gut-Brain Interaction.

The American journal of gastroenterology·2026
Same author

Key recommendations to improve equity and access in colorectal cancer screening for rural and remote communities. A grounded theory study.

Australian and New Zealand journal of public health·2025
Same author

"It's My Wish, We Need This Program": Qualitative Reflections From People With High-Grade Brain Cancer Consenting to Postmortem Brain Donation.

JCO oncology practice·2025
Same author

Mechanisms of action and clinical effectiveness of herbal treatments for disorders of gut-brain interaction.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025

Related Experiment Video

Updated: Mar 25, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

7.1K

Women and functional dyspepsia.

Kate Napthali1, Natasha Koloski1, Marjorie M Walker1

  • 1Faculty of Health & Medicine, University of Newcastle, Callaghan, NSW, 2308, Australia.

Women'S Health (London, England)
|February 23, 2016
PubMed
Summary

Functional dyspepsia is common but poorly understood, affecting women disproportionately. Current treatments are limited, highlighting the need for effective therapies for this digestive disorder.

Keywords:
Helicobacter pylorifunctional dyspepsiaprokineticsproton pump inhibitors

More Related Videos

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

1.3K
Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
04:04

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

1.1K

Related Experiment Videos

Last Updated: Mar 25, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

7.1K
Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

1.3K
Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
04:04

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

1.1K

Area of Science:

  • Gastroenterology
  • Digestive Health
  • Clinical Medicine

Background:

  • Functional dyspepsia (FD) is a prevalent gastrointestinal disorder with unclear pathophysiology.
  • The Rome III criteria are the most widely accepted diagnostic guidelines for FD.
  • FD significantly impacts patients' quality of life and healthcare utilization.

Purpose of the Study:

  • To review the epidemiology, pathophysiology, and impact of functional dyspepsia, with a specific focus on women.
  • To summarize current diagnostic criteria and available treatment options for FD.
  • To identify unmet needs in FD management and explore potential novel therapeutic strategies.

Main Methods:

  • Literature review of epidemiological data, clinical studies, and treatment guidelines for functional dyspepsia.
  • Analysis of pathophysiology, including potential roles of duodenal eosinophilia.
  • Evaluation of current therapeutic regimens, including proton pump inhibitors and prokinetic agents.

Main Results:

  • Functional dyspepsia affects a significant portion of the population, with a notable impact on women.
  • Standard treatments like proton pump inhibitors and prokinetics are used post-H. pylori eradication.
  • Novel agents like acotiamide show promise, but a universally effective and safe treatment remains elusive.

Conclusions:

  • Despite its prevalence, functional dyspepsia remains poorly understood, necessitating further research.
  • Current management strategies for FD offer limited efficacy, underscoring the need for improved therapeutic options.
  • Developing safe and effective treatments for functional dyspepsia is a critical unmet medical need.